B. Ostenstad

发表

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment.

A. Tierens, S. Dudman, O. Hungnes, 2011, Blood.

Disodium pamidronate versus mithramycin in the management of tumour-associated hypercalcemia.

B. Østenstad, B. Ostenstad, O. Andersen, 1992, Acta oncologica.

Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area.

B. Østenstad, E. Schlichting, T. Lea, 1994, Gut.

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.

J. Bergh, P. Malmström, L. Hakamies‐Blomqvist, 2000, European journal of cancer.

Interleukin-2 receptor levels in non-Hodgkin's lymphoma. Correlation to histological degree of malignancy and presence of constitutional symptoms.

B. Ostenstad, J. Tangen, A. F. Abrahamsen, 1990, Acta oncologica.

Limited heterogeneity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours.

B. Østenstad, E. Schlichting, T. Lea, 1994, British Journal of Cancer.

Evidence for monoclonal expansion of synovial T cells bearing V alpha 2.1/V beta 5.5 gene segments and recognizing a synthetic peptide that shares homology with a number of putative autoantigens.

O. Førre, T. Lea, M. Sioud, 1995, Immunology.

Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial

B. Sander, J. Delabie, A. Feldman, 2022, Blood.

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

K. Wester, H. Lundqvist, C. Blomqvist, 2004, British Journal of Cancer.

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.

J. Delabie, H. Holte, M. Karjalainen‐Lindsberg, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group.

J. Bergh, C. Blomqvist, B. Østenstad, 1999, European journal of cancer.

Soluble interleukin-2 receptor levels in patients with malignant melanoma and renal cell cancer.

B. Ostenstad, 1992, Acta oncologica.

Identification of immunogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinoma tumour.

M. Sioud, B. Ostenstad, M. Hansen, 2001, International journal of oncology.